United States of America, ex rel. Ian Dixon, Karl Quist, and Sara Stovall v. Sentara Health Plans f/k/a Optima Health Plan, Sentara Health f/k/a Sentara Healthcare, and Milliman, Inc.

District Court, W.D. Virginia·Decided July 31, 2026·No. 3:20-cv-00062·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT CLERKS OFFICE US DISTRICT COURT FOR THE WESTERN DISTRICT OF VIRGINIA AT CHARLOTTESVILLE, VA FILED CHARLOTTESVILLE DIVISION July31 ,2026

LAURA A. AUSTIN, CLERK UNITED STATES OF AMERICA, ex rel. ) BY: /s/ Nik Sams IAN DIXON, KARL QUIST, and SARA ) DEPUTY CLERK STOVALL, ) ) Plaintiffs, ) Civil Action No. 3:20-cv-00062 ) v. ) ) By: Elizabeth K. Dillon SENTARA HEALTH PLANS f/k/a ) Chief United States District Judge OPTIMA HEALTH PLAN, SENTARA ) HEALTH f/k/a SENTARA HEALTHCARE, ) and MILLIMAN, INC., ) ) Defendants. )

MEMORANDUM OPINION

Relators Ian Dixon, Karl Quist, and Sara Stovall brought this qui tam action against defendants Sentara Health Plans (f/k/a Optima Health Plan), Sentara Health (f/k/a Sentara Healthcare) (collectively, Sentara), and Milliman, Inc. The case was initially maintained under seal while the United States considered whether to intervene. After the United States declined to intervene, the court unsealed the case. Relators then filed a First Amended Complaint (FAC), which is the operative complaint. (Dkt. No. 108.)1 Most of the actions that Relators challenge as fraudulent were taken by Optima Health Plan (Optima) in conjunction with its actuary, Milliman. Sentara Health is Optima’s parent corporation and is also alleged to have participated in the fraud. Pending before the court are two motions to dismiss, one filed by Sentara and the other by Milliman. (Dkt. Nos. 134, 136.) The motions seek dismissal on various grounds, but the

1 Throughout this opinion, references to page numbers in the record are to the page numbers supplied by the court’s Case Management/Electronic Case Filing (CM/ECF) system, rather than the numbers the parties supplied. court relies only on one.2 The court determines that the federal filed-rate doctrine bars the claims here, which directly challenge rates approved by the Virginia Bureau of Insurance (BOI), a Virginia regulatory agency. BOI acted under federal authority to approve premium rates for insurers offering health insurance through the Virginia Marketplace under the Affordable Care Act, the same rates Relators challenge as fraudulent and unreasonable. For this reason, both

motions to dismiss will be granted. Also pending before the court are two motions to strike filed by Relators, each titled as a “Motion to Disregard Exhibits.” (Dkt. Nos. 149, 150.) They ask the court to strike various documents attached to the motions to dismiss, which Relators contend the court may not consider when ruling under Rule 12(b)(6). Because the court does not rely on any factual materials outside the FAC, the motions to strike will be denied as moot. I. BACKGROUND

A. Overview of Affordable Care Act’s Rate-Approval Process In this section, the court provides a broad overview of the FAC’s factual allegations, and additional relevant details are discussed in context in Section III. Many of the FAC’s detailed factual allegations, however, are irrelevant to the court’s ruling. The Affordable Care Act (ACA) is a federal healthcare reform law enacted in March 2010. The ACA required each state to establish a health insurance marketplace (Exchange) where individuals could purchase health insurance coverage. 42 U.S.C. § 18031(b)(1). Virginia opted for a federally facilitated Exchange accessible online at HealthCare.gov. (FAC ¶¶ 22–24.) An insurer that wants to participate in Virginia’s Exchange as a Qualified Health Plan must submit an annual application to the Centers for Medicare & Medicaid Services (CMS), an

2 Defendants also urge dismissal on the grounds that the public-disclosure bar of the False Claims Act bars Relators’ claims and that Relators have failed to state facts sufficient to plausibly state their claims. agency within the U.S. Department of Health and Human Services. The application must include proposed rates for insurance premiums on its offered plans, which must be supported by specific explanations and documentation, as well as an actuarial memorandum supporting the proposed rates. (FAC ¶¶ 27–33.) The actuarial memorandum certifies that the rates set forth in the insurer’s application are neither excessive nor deficient. (Id. ¶ 49.) The insurer also must

provide an attestation agreeing to the relevant certification standards in various federal regulations. (Id. ¶ 47.) The rate application is submitted to CMS, who delegates its review authority in Virginia to BOI, a subagency of the State Corporation Commission (SCC). If BOI/SCC approves the rates, then CMS adopts SCC’s recommendation where SCC has provided a “final determination of whether a rate increase is unreasonable [or reasonable], which must include a brief explanation of how its analysis of the relevant factors set forth in [45 C.F.R.] § 154.301(a)(3) caused it to arrive at that determination.” (FAC ¶ 52 (quoting 45 C.F.R. § 154.210(b)(2)).) The ACA also created a premium tax credit for certain eligible individuals. (See FAC

¶¶ 54–63.) In very broad terms, and as relevant to Relators’ allegations, most eligible enrollees choose to have their tax credit paid directly to the insurer by the government to reduce the individual’s insurance premium, rather than claiming it afterward on their tax returns. These advanced premium tax credits, or APTCs, are calculated based on an insurer’s premiums and the individual’s income, and higher premiums generally result in higher tax credits. In exchange for the APTCs, insurers must reduce premiums payable by eligible individuals and notify the Exchange and HHS of the reductions. B. Optima’s 2018 and 2019 Rate Applications In August 2017, Anthem, Optima’s leading competitor, announced that it was withdrawing from the ACA’s individual health-insurance marketplace, leaving Optima as the sole remaining insurer across portions of Virginia. (FAC ¶ 1.) At that time, Optima had already submitted a rate-filing justification to Virginia regulators for 2018. (Id. ¶ 65.) In September

2017, Optima, assisted by Sentara and Milliman, submitted a revised rate filing that contained a significant rate increase of 81.8% statewide. (Id. ¶¶ 2, 77.) Relators accuse Milliman and Optima of “leverag[ing] Optima’s monopoly position in certain geographic markets[, where it would be the only insurer offering plans,] by grossly inflating insurance premiums in violation of the ACA.” (FAC at 15 (heading).) BOI approved the rate increase, even though it was “the largest rate increase in the history of the ACA” for insurers having at least 1,000 enrollees. (Id. ¶ 83.) For some families, switching from Anthem’s cheapest plan in 2017 to Optima’s in 2018 would increase their premiums more than 200%. (FAC ¶ 78.) Relators suggest that Optima and

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America, ex rel. Ian Dixon, Karl Quist, and Sara Stovall v. Sentara Health Plans f/k/a Optima Health Plan, Sentara Health f/k/a Sentara Healthcare, and Milliman, Inc., (W.D. Va. 2026).

United States of America, ex rel. Ian Dixon, Karl Quist, and Sara Stovall v. Sentara Health Plans f/k/a Optima Health Plan, Sentara Health f/k/a Sentara Healthcare, and Milliman, Inc. (United States of America, ex rel. Ian Dixon, Karl Quist, and Sara Stovall v. Sentara Health Plans f/k/a Optima Health Plan, Sentara Health f/k/a Sentara Healthcare, and Milliman, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Keogh v. Chicago & Northwestern Railway Co.
260 U.S. 156 (Supreme Court, 1922)
Arkansas Louisiana Gas Co. v. Hall
453 U.S. 571 (Supreme Court, 1981)
Hui v. Castaneda
559 U.S. 799 (Supreme Court, 2010)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Town of Norwood v. New England Power Co.
202 F.3d 408 (First Circuit, 2000)
Coll v. First American Title Insurance
642 F.3d 876 (Tenth Circuit, 2011)
Wegoland Ltd. v. Nynex Corp.
27 F.3d 17 (Second Circuit, 1994)
Edwards v. City of Goldsboro
178 F.3d 231 (Fourth Circuit, 1999)
Wag More Dogs, Ltd. Liability Corp. v. Cozart
680 F.3d 359 (Fourth Circuit, 2012)
McCray v. Fidelity National Title Insurance
682 F.3d 229 (Third Circuit, 2012)
Katz v. Fidelity National Title Insurance
685 F.3d 588 (Sixth Circuit, 2012)
Giarratano v. Johnson
521 F.3d 298 (Fourth Circuit, 2008)